N-(4-Cyanophenyl)-3,4-Difluorobenzamide
| Purity | Grade | Package | Stock | Price | Quantity |
|---|---|---|---|---|---|
| 97% | RG | 250MG | In Stock | 114 USD | |
| 97% | RG | 1G | In Stock | 350 USD | |
|
Should you have any questions, please contact us by Email. |
|||||
Applications of 1007802-68-7
N-(4-Cyanophenyl)-3,4-difluorobenzamide has several potential applications:
- Pharmaceutical Development: Due to its biological activity, it can be explored as a lead compound in drug discovery for treating hypertension or infections.
- Material Science: Its unique structure may lend itself to applications in developing advanced materials with specific electronic or optical properties.
Biological Activity of 1007802-68-7
Research indicates that N-(4-Cyanophenyl)-3,4-difluorobenzamide exhibits significant biological activity, particularly in pharmacological contexts. Studies have shown:
- Antihypertensive Effects: The compound has been investigated for its potential to lower blood pressure, demonstrating efficacy in experimental models.
- Antimicrobial Properties: Preliminary studies suggest that it may possess antimicrobial activity, making it a candidate for further investigation in drug development.
Download COA of 1007802-68-7
Bulk Packaging Price Explanation of 1007802-68-7
Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.
Purchase Instructions of 1007802-68-7
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
